News | March 11, 2011

FDA Issues Safety Notification for California Imaging Center

March 11, 2011 - The U.S. Food and Drug Administration (FDA) is alerting referring physicians of poor quality reads on mammography exams at Huntington Radiology in Huntington Park, Calif.

The FDA said the safety notification concerns patients who had a mammogram at Huntington Radiology between Sept. 9, 2008, and Sept. 9, 2010. The FDA said it became aware of problems associated with the quality of mammograms performed at the facility. The FDA worked with the American College of Radiology (ACR) to perform a review of a sample of mammograms performed by Huntington Radiology that included images taken between Sept. 9, 2008, and Sept. 9, 2010. Results from that review included poor-quality mammograms with possibly unreliable results.

Under the Mammography Quality Standards Act (MQSA) of 1992, the FDA requires that all mammography facilities meet certain high-quality standards. This facility did not meet standards for mammography quality under that Act. The facility has not performed mammography exams since Sept. 9, 2010, because ACR revoked its accreditation and its MQSA certificate is no longer in effect.

Although Huntington Radiology has sent letters to patients and their referring healthcare providers, it has been unable to demonstrate to FDA’s satisfaction that all affected patients were successfully notified. The FDA said it is alerting patients who had mammograms at this facility between the dates in question. The agency said this does not mean that the results of all of the examinations were inaccurate, but patients might need to have their mammograms re-evaluated and possibly repeated.

For more information: [email protected]

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...